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What’s Known on This Subject: Acute pancreatitis in childhood is a relatively rare but 
potentially serious condition. In the past, trauma and mumps have been the commonest 
associations. No study has ever estimated incidence within a childhood population on a 
prospective basis. 
What This Study Adds: Acute pancreatitis has a childhood incidence in the UK of 0.78 per 
100,000/year (95%CI 0.62-0.96). Gallstones and drug therapy are now the most commonly 
identified associations whilst mumps and trauma are identified rarely. Children of Pakistani 
heritage are disproportionately affected. 
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 ABSTRACT  
 
Objectives: To establish the UK incidence and clinical associations of acute pancreatitis (AP) 
in children aged 0–14 years. 
 
Methods: Monthly surveillance of new cases of AP in children under 15 years of age through 
the British Paediatric Surveillance Unit conducted from April 2013 to April 2014 (inclusive) 
followed by one year administrative follow-up for all valid cases. 
 
Results: 94 cases (48 boys) fulfilled the diagnostic criteria. The median age at diagnosis was 
11.2 years (range 1.3–14.9). White children accounted for 61% of the cases compared to 28% 
from Asian and 5% from African ethnicities. Pakistani children accounted for 18 of 26 (69%)  
Asian patients and 19% of the total cohort.  The incidence of AP in children in the UK was 0.78 
per 100,000/year (95%CI 0.62–0.96). The incidence in Pakistani children (4.55; 95%CI 2.60-
7.39) was 7-fold greater than White children (0.63; 95%CI 0.47-0.83). Of the 94 cases: 35 
(37%) were idiopathic or associated with drugs 18 (19%), gallstones 12 (13%), hereditary 7 
(7%), organic acidaemias 7 (7%), anatomical anomalies 5 (5%), viral infections 3 (3%), 
systemic diseases 2 (2%) and trauma 1 (1%). The most common drug associations were 
asparaginase (28%), azathioprine (17%) and sodium valproate (17%).  
 
Conclusions: Whilst still relatively uncommon in the UK, on average there is more than one 
case of childhood AP diagnosed every week. The associations of AP have changed 
significantly since the 1970/80’s.  Over-representation of Pakistani children is worthy of further 
investigation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 INTRODUCTION:  
Acute pancreatitis (AP) is an acute inflammatory condition of the pancreas with variable 
involvement of peri-pancreatic tissues and/or distant organ systems.1 AP is uncommon in 
children, but leads to significant morbidity in the short, medium and long-term. Recently, an 
increase in the number of paediatric AP cases in single institutions has been reported by centres 
in the USA,2-5  Australia,6  and Mexico.7 However, these studies are retrospective reviews and 
the incidence of AP is usually reported as an absolute number of cases per centre per year at 
individual referral institutions. 
 
There is no recent UK data on AP in childhood and no robust estimate of incidence. Sibert  
conducted a retrospective review of all pancreatitis cases (acute and chronic) admitted to 
hospital in the Newcastle area and Wales between 1968 and 1975 and estimated the annual rate 
of diagnosis of pancreatitis in children under 16 years at approximately 1/400,000 in Newcastle 
and 1/250,000 in Wales.8 Until now, no national population-based study has been conducted, 
either prospectively or retrospectively, to investigate the frequency of this condition in 
children, in the UK or elsewhere.  
 
In adults, the most common causes of AP are alcohol and gallstones,9,10 but in children it is 
associated with a wide variety of potential aetiologies, including abdominal trauma, drug 
therapy, infections, systemic diseases and congenital anatomical anomalies.2,11  Trauma and 
mumps were the commonest associations reported in the UK in the 1970/80’s.8,12,13 However, 
there has been no effort to re-examine the associated agents of this disease in the UK in the last 
three decades. The last study conducted within the UK was performed in Scotland in the 1990s 
on retrospective data from 1978-1992, where mumps (39%) and trauma (14%) were the most 
frequent associations.13  
 Several changes in population characteristics, including the introduction of the MMR vaccine 
in 1988 and an increase in the prevalence of obesity-associated gallstones among children,14  
may have changed the incidence and causative agents responsible for this relatively rare 
condition in childhood. Therefore, the aims of this study were to conduct the first prospective 
examination of the incidence of AP in UK children and to determine its current clinical 
associations. 
 
METHODS 
We conducted a prospective monthly surveillance of over 3,700 consultant paediatricians and 
paediatric surgeons in the UK and Ireland using the British Paediatric Surveillance Unit 
(BPSU) of the Royal College of Paediatrics and Child Health (RCPCH) to detect all new cases 
of AP in 0- to 14-year-old children. The BPSU is an active reporting system where an orange 
card containing a list of conditions is sent monthly, by post or electronically, to all consultant 
paediatricians and other specialists where appropriate.  Respondents report cases they have 
seen in the previous month for conditions named on the card, or to tick a "Nothing to report" 
box. Following the return of the card to the BPSU, the research team are informed of the 
reporting clinicians’ details who receive a short proforma asking for clinical details, this is 
returned to the researcher for analysis.15,16 AP in children under 15 years of age was included 
on the card for 13 months (April 2013 to April 2014 inclusive). The orange card return 
compliance was 95.3% during the study period. To identify children directly referred to 
surgical departments, the British Association of Paediatric Surgeons (BAPS) supported this 
study and paediatric surgeons received the orange card. Almost all paediatricians belong to the 
RCPCH and thus receive ‘orange cards’. The vast majority of paediatric surgeons are members 
of BAPS or RCPCH. No general or emergency physicians in the UK manage children with AP 
without referral to one of the above. 
 Clinicians were asked to report any child under the age of 15 years seen in the previous month 
with a new diagnosis of AP. Diagnosis of AP required at least two of the three following 
features: (1) Acute onset of upper abdominal pain; (2) Serum amylase and/or lipase raised ≥3 
times the upper limit of normal local range; and (3) Imaging findings characteristic of AP. 
These criteria for diagnosis of AP were adapted according to revised Atlanta criteria,17 and a 
consensus of the “International Study Group of Paediatric Pancreatitis: In Search for a Cure” 
(INSPPIRE).18  
Reporting clinicians were contacted with an initial study questionnaire to collect information 
about the patient, clinical presentation, diagnostic details, consultant at discharge and again at 
one year post diagnosis.  Upon receipt of a completed initial study questionnaire, the eligibility 
of the patient and case status was determined. This included the age of the child, time of 
diagnosis and fulfilment of the study case definition. The clinicians’ diagnoses were reviewed 
by the study investigators (A.A.M., J.H.S., P.J. and E.C) in light of the questionnaire data 
supplied.  Clinical associations were accepted after the investigators’ review and special 
considerations. For example, viral infection and hereditary pancreatitis were only recorded, as 
an association if a confirmatory serology test or genetic testing, were conclusive. Associations 
were updated at the end of the follow-up period. Cases with no identifiable association were 
then classified as idiopathic. If a child had more than one episode of AP during the study period, 
only the first episode was included as a new case.  
 
Ethics approval  
The study was approved by The National Research Ethics Service (NRES) Committee South 
West – Central Bristol – (REC reference 11/SW/0132) and was granted Section 251 of the 
National Information Governance Board for Health and Social Care (NIGB) permission by 
NIGB Ethics and Confidentiality Committee (ECC) under reference ECC 6-02(FT12)/2012.  
 Statistics  
The incidence rate was calculated using the valid cases from the first 12 consecutive months 
and the population denominator obtained from “Population Estimates Summary for the UK, 
mid-2013” table, published by the Office for National Statistics.19 Ethnicity specific incidence 
rates of AP were calculated for English and Welsh children only using the “Ethnic group by 
age in England and Wales 2011” data.20 The ethnic groups by age were only available for these 
two countries. 95% confidence intervals for rates were calculated using an 'exact' method for 
Poisson. Poisson regression models were used to compare the rates for the main ethnic groups. 
The statistics software SPSS (Version 21.0. Armonk, NY: IBM Corp) and Stata vs 12.1 
(StataCorp LP, Texas, 1985-2011) were used for analysis. A 5% level of significance was used.  
 
RESULTS 
220 case notifications were received over the 13 months of the study. Of these, 202 (92%) 
responses to the initial study questionnaire were received and the remaining 18 cases had no 
response. 133 episodes met the diagnostic criteria for AP during the study period; 95 were 
newly confirmed cases (94 from the UK and 1 from Ireland), 20 were duplicates and 18 were 
recurrent episodes. Sixty-nine cases were excluded because they did not fulfil the case 
definition or were diagnosed outside the study period. 94 UK newly confirmed cases were 
included in the final analysis and 88 of these, who had been diagnosed in the first 12 
consecutive months of the study period, were used in the calculation of the incidence. 
Of the 94 UK cases, 46 were girls; the female to male ratio was approximately 1:1. The median 
age at diagnosis was 11.2 years, (range 1.3 to 14.9 years).  The cases were evenly distributed 
throughout the year, with no discernible seasonal trend. White children accounted for 61% of 
cases compared to 28% from Asian and 5% from African ethnic groups. Children of Pakistani 
origin accounted for the majority (18 of 26; 69%) of Asian heritage cases and 19% of the total 
 cohort.  Eighty-eight of ninety-four cases (94%) were screened using amylase, eighteen (19%), 
had amylase and lipase levels measured and six cases were screened using lipase alone. Twelve 
children developed AP whilst in hospital during management for other conditions. In only one 
case was diagnosis made in intensive care unit. 
 
Incidence rates  
The estimated UK population under 15 years of age in mid-2013 was 11,307,400, giving a 
national incidence of AP in children aged 0–14 years of 0.78 per 100,000/year (95%CI 0.62-
0.96). The specific incidence rates of AP in different ethnic groups in England and Wales are 
shown in Table 1.  
Table 1. Ethnicity specific incidence rates for acute pancreatitis in 0-14 years olds in England 
and Wales  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Poisson regression was used to compare the rates for the 5 main groups (labelled 1 to 5 in the first column).    
There were significant differences between the 5 groups (P<0.001 overall). Group 3 was significantly higher 
than group 1 (P<0.001) whereas the other groups 2, 4 and 5 were not significantly different from 1 (min 
P=0.49). 
 
Group                   Ethnicity Population No of cases            Rate per 100,000a  95% CI 
 
 
All Ethnicities 
   
9,891,138 
     
    83 
     
  0.84  
 
0.67-1.04 
 
1 
 
White: Total 
    
7,781,925 
    
    49 
     
  0.63 
 
0.47-0.83 
 
2 
 
Mixed: Total 
    
523,782 
    
    2 
     
  0.38 
 
0.05-1.38 
             White and Asian 154,176     1   0.65 0.02-3.61 
             Other Mixed 114,303     1    0.88 0.02-4.87 
 
3 
 
Asian: Total 
    
979,148 
     
    24 
     
  2.45 
 
1.57-3.65 
             Indian 255,892     2   0.78 0.10-2.82 
             Pakistani 351,384     16   4.55 2.60-7.39 
             Bangladeshi 146,817     3   2.04 0.42-5.97 
             Other Asian 178,704     3   1.68 0.35-4.91 
 
4 
 
Black: Total 
    
478,863 
      
    4 
     
  0.84 
 
0.23-2.14 
             African 281,495     4   1.42 0.39-3.64 
 
5 
 
Other: Total 
    
127,420 
     
    1 
     
  0.79 
 
0.02-4.37 
 Ethnicity not known  
      
    3 
 
  
 Clinical associations 
The main clinical associations of AP in the 94 children are listed in Table 2. Thirty-five cases 
(37%) had no reported associated agents and were classified as idiopathic. The most common 
associations identified were drug therapy (19%) and gallstones (13%). The majority of the 35 
idiopathic cases were in older age groups: 17 (49%) cases in the 10–14 age group and 14 (40%) 
in the 5–9 age group, compared to only 4 (11%) in the 0–4 group (2 were under 3 years). Of 
the 12 gallstone-associated cases, five were boys; body weight of 5 cases was above the 91st 
centile (4 were above the 98th centile) and 2 cases had chronic haemolytic disease (hereditary 
spherocytosis and sickle cell disease).  Overall, 6 of 7 organic acidaemia cases (86%) and 3 of 
5 asparaginase (leukaemia treatment)-associated cases (60%) were of Pakistani ethnicity.  One 
child had recessive familial hypertriglyceridaemia. The triglyceride level, after fluid therapy, 
was 4.8 mmol/L (normal range 0.4-2.1 mmol/L).   
  
 Table 2. Clinical associations of acute pancreatitis in 94 children < 15 years old in the UK 
 
Clinical association                                                                                
  
No (%)
 
Idiopathic 
 
 
 
35 (37) 
 
Drugs 
  
18 (19) 
    Asparaginase 5  
    Azathioprine 3  
    Sodium valproate 3  
    Methylprednisolone 1  
    Mercaptopurine 1  
    Mesalazine 1  
    Carbamazepine 1  
    Clarithromycin 1  
    Opiates 1  
    Calcium carbonate/Alfacalcidol 1  
 
Gallstones 
 
 
 
12 (13) 
 
Hereditary 
  
7 (7) 
    SPINK1 gene positive 5  
    PRSS1 gene positive 2  
 
Organic acidaemias 
  
7 (7) 
    Propionic acidaemia 4  
    Methylmalonic acidaemia 2  
    Isovaleric acidaemia 1  
 
Anatomical anomalies 
  
5 (5) 
    Pancreas divisum 3  
    Choledochal cyst 2  
 
Viral Infections 
  
3 (3) 
    Mumps 1  
    EBV & CMV 1  
    Rotavirus 1  
 
Systemic diseases 
  
2 (2) 
    Systemic lupus erythematosus 1  
    Henoch Schonlein Purpura 1  
 
Trauma 
  
1 (1) 
    Handle bar injury 1  
 
Others 
  
4 (4) 
    Cystic Fibrosis 2  
    Hypertriglyceridaemia 1  
    Alpha 1-antitrypsin deficiency 1  
 
Abbreviations: SPINK1, Serine Peptidase Inhibitor, Kazal Type 1; PRSS1, Protease, Serine, 1 (Trypsin 1); 
EBV, Epstein–Barr virus; CMV, Cytomegalovirus. 
 
 
 
 DISCUSSION  
This study demonstrates that childhood AP remains an uncommon disease in the UK: the 
incidence of AP in children under 15 years old was 0.78 per 100,000/year (95%CI 0.62-0.96). 
To the best of our knowledge, this is the first prospective, nationally based estimation of 
childhood AP worldwide. Only one previous retrospective study has been conducted in the 
UK, but it was primarily designed to examine the aetiology, complications and outcomes of 
pancreatitis in children. It also estimated the incidence in only two regions8. Although the 
previous study included all cases of pancreatitis and children up to age 16 years, our incidence 
rate is double that estimated in Wales (0.4/100,000/year) and three-fold higher than Newcastle 
(0.25/100,000/year).8 This apparent increase in the UK incidence might be due to an increase 
in clinical awareness or to the change in its clinical associations, which was reflected by an 
increase in the proportion of some previously known associations, such as drugs, and the 
appearance of new associations not previously reported, such as organic acidaemias.  
We were unable to compare our incidence findings with Europe as no data exists. The rate of 
childhood AP reported here for the UK was lower than that reported for Australia (2.5/100,000 
in 1993 and 3.6/100,000 in 2002),6 and the USA (2.4/100,000 in 1993 and 13.2/100,000 in 
2004).3 However, both of these studies were retrospective reviews conducted at major 
paediatric referral centres and the cases of AP were detected by either reviewing hospital 
laboratory databases,6  or hospital discharge records.3 The retrospective nature, referral bias 
and variation in the diagnostic criteria and age groups of these studies may explain these 
differences. In addition, the Australian study had a higher number associated with trauma 
(36%) and systemic disease (22%),6  than our study (1% for trauma and 2% for systemic 
diseases), which might also have led to a higher incidence in  Australia than the UK .  
 More than a quarter of our patients were of Asian or British Asian origin (28%). Interestingly, 
Pakistani children alone accounted for about one fifth (19%) of the cohort, although they 
constitute only 3.6 % of the population ˂ 15 years of age in England and Wales.20 As a result, 
the incidence in Pakistani children (4.55; 95%CI 2.60-7.39) was seven-fold higher than in 
White children (0.63; 95%CI 0.47-0.83) (data for England and Wales only). All seven of the 
organic acidaemia cases, which represent disorders caused by inherited inborn errors of 
metabolism, were of Asian heritage and the majority of these (6 out of 7) were Pakistani. This 
may reflect the tradition for first-degree marriage amongst this ethnic group and may in part 
explain the overrepresentation of Pakistani children in our data. As three of five asparaginase-
associated cases were of Pakistani heritage, further investigation to determine whether 
Pakistani children have a higher incidence of leukaemia or are more sensitive to asparaginase 
than others is warranted.  
 
This study shows that childhood AP has a wide variety of clinical associations in the UK, as in 
other countries; however, more than one third of the cases (37%) were idiopathic. It should be 
noted that all idiopathic cases had imaging for gallstones, but only 20% were screened for 
genetic causes, as the policy in the UK seems to be to screen mainly in cases with a history of 
recurrent pancreatitis. We found that associations of AP in this country have changed 
significantly compared to data from the previous four decades. Medication (19%) and 
gallstones (13%) were the commonest associations, whilst trauma (1%) and mumps (1%) were 
uncommon in our patients. Despite recent advances in diagnostic techniques, including 
pancreatico-biliary imaging and genetic testing, we found a high proportion of idiopathic AP 
in UK children although this was within previously reported national ranges of 25–56%.8,12,13 
Idiopathic AP seems to be more common in children. It has been reported globally in a wide 
range of proportions in children, from 15 to 36% of total cases.6,7,21-28 Lopez did not find 
 idiopathic pancreatitis in children under age 3,5 but the present study supports Kandula’s 
findings that idiopathic cases can be detected at this young age.29 
In 19% of our cases, AP was associated with drug therapy. The majority of these drugs 
(asparaginase, azathioprine, sodium valproate, methylprednisolone, mercaptopurine and 
opiates) are a known association,30 and others (mesalazine, carbamazepine and clarithromycin) 
are recognised as possible inducers of AP.30,31 In one case, AP was associated with 
hypercalcaemia secondary to over-replacement of vitamin D/oral calcium  (alfacalcidol and 
calcium carbonate); a similar case was reported recently in an adult patient from the UK.32 
Asparaginase, azathioprine and sodium valproate, which are used for treatment of leukaemia, 
inflammatory bowel diseases and epileptic disorders, respectively, were the most commonly 
associated medications in our series. This is similar to previous paediatric findings.2,24,25 
Asparaginase-associated pancreatitis has been reported in 6.7–18% of cases following 
leukaemia treatment in children,33 but the risk was only 1.5% in children and young adults with 
acute lymphoblastic leukaemia in the UK.34  
Gallstones were the second most frequent association, accounting for 13% of the total patients, 
compared to 4% in a previous study in Scotland,13 and no cases in other UK series.8,12 
Gallstones were not exclusively associated with the overweight or haemolytic diseases, as 5 
out of 12 cases had no recognised risk factors. The proportion of gallstone cases in our study 
(13%) was comparable to recent studies from France (13%),23  and America (12%),24 and 
higher than in Italy (6%),25 but less than the 26% reported in another large American study.4  
We found trauma and mumps, previously the most commonly reported associations in the UK, 
to have become uncommon. Mumps was previously responsible for 16–39% of AP cases in 
the UK,8,12,13 but we found only one case. This probably reflects the introduction of the MMR 
vaccine in 1988. The most surprising finding in the present study was that only one case was 
 associated with trauma during the study period. Trauma accounted for 13–16% of UK cases in 
the past,8,12,13 and has been reported in 8-59% of children with AP internationally.2,4-
6,21,23,24,29,35,36 One explanation might be that children these days are overly protected by their 
parents, less active, and spend more time sitting watching TV or playing electronic games than 
being outdoors. In addition, the younger age of our cohort may also be pertinent, as trauma is 
more common in older teenagers.  
Recent case series of AP in children from Italy, France and America indicated 
familial/hereditary AP in 6%, 8% and 1% of patients, respectively.23-25 Seven of the children 
(7%) in our study who had recurrent episode/s were diagnosed with hereditary pancreatitis. 
Although AP is a known complication of organic acidaemias,37,38 this was not reported in 
previous studies from this country. We found seven cases (7%), all of Asian origin, associated 
with these rare inherited disorders. In total, 5% of our cases were attributed to anatomical 
congenital anomalies (pancreas divisum and choledochal cyst); which is similar to the 5% 
reported in America,24  but much lower than the 23% and 43% reported in Taiwan and 
Japan.21,27 Anatomical anomalies, particularly choledochal cyst, are known to be more common 
in Asian than in Western children.27 
Two cases in our study were associated with systemic diseases, namely systemic lupus 
erythematosus and Henoch Schonlein purpura. AP has been associated with systemic diseases 
in 2–53% cases in paediatric series.2,4-6,21,23,24,26,29 This variation may be partly due to 
differences in the definition of AP and age of patients and to the variations in classification and 
assigning the associated agents. The changing incidence in Australia was attributed in part to 
an increase in cases associated with systemic illnesses.6  
The main limitation of this study is the potential underestimation of incidence resulting from 
incomplete ascertainment inherent in the use of the BPSU methodology. Although the orange 
 card return compliance during the survey period and clinician responses for case information 
were high, at 95% and 92%, respectively, data collection solely through the BPSU may have 
resulted in incomplete ascertainment. In addition, it is possible that some mild cases or AP in 
those too young to exhibit classical abdominal pain were simply not diagnosed by clinicians 
caring for the children in primary or secondary care, and thus not reported. Despite this, the 
study provides the first epidemiological data on AP in children and its current associations.  
 
CONCLUSION 
This study shows that AP is an uncommon disease in young children in the UK, but is possibly 
becoming more frequent. Childhood AP has diverse clinical associations while more than one 
third of cases are idiopathic. The associations of childhood AP in the UK have changed 
significantly in the last four decades. Young patients of Pakistani ethnicity, with organic 
acidaemias or who are undergoing treatment with asparaginase, are at greater risk for 
developing AP and the diagnosis should be considered early in the management of abdominal 
symptoms. The over-representation of Pakistani children observed in this study merits further 
investigation.  
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